Atlas Trials

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Clinical trial NCT02726334 · TERMINATED

Trial details

NCT number
NCT02726334
Sponsor
Bionomics Limited
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2016-03-01
Primary completion
2017-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.